Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Frédéric Altare(Centre National de la Recherche Scientifique), Jean‐Laurent Casanova(Howard Hughes Medical Institute), Anthony W. Segal(Soroka Medical Center), Dinakantha Kumararatne(Hôpital Necker-Enfants Malades), Edgar Meinl(Ludwig-Maximilians-Universität München), Alain Fischer(Inserm), Françoise Bernaudin(Université Paris-Est Créteil), Jared Gollob(Université Paris-Sud), Salma Lamhamedi(Hôpital Necker-Enfants Malades), David A. Lammas(Hôpital Necker-Enfants Malades), Emmanuelle Jouanguy(Inserm), Jean‐François Emile(Inserm), Olle Jeppsson(Hôpital Necker-Enfants Malades), Françoise Le Deist(Centre National de la Recherche Scientifique), Rainer Döffinger(Hôpital Necker-Enfants Malades), Pam Drysdale(Hôpital Necker-Enfants Malades), Anne Durandy(Hôpital Necker-Enfants Malades)
Cited by 840
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k